Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
2 participants
OBSERVATIONAL
2014-02-28
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus
NCT05051709
Hallux Valgus- Radiological and Clinical Predictors for Outcome After Surgery
NCT04851249
The Toe-spread-out Exercise in Patients With Hallux Valgus and Without the Deformity
NCT03423498
Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot
NCT06874517
Proximal Metatarsal Osteotomy in Correction of Hallux Valgus
NCT06584487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data collected will come from a comprehensive examination. Methods will include the measurement of arch motion made by an examiner using a device and a fluoroscopic gait examination procedure, and completion of two medical questionnaires. The fluoroscopic acquisition of the digital images will be analyzed across the specified time dimensions of the gait cycle.
Device and fluoroscopy of measures of arch motion will be made at 2 time points on patients enrolled in this study: presurgery (baseline) and 6 months postsurgery. The questionnaire measurements of self-reported pain and function will be made at 4 time points: presurgery (baseline) and again at 3 months, 6 months, and 12 months postsurgery. Outcome measurements will be collected on control subjects at one time point only, on the day of their enrollment into the study.
Prospective studies have not characterized outcomes in patients receiving this type surgical fusion as part of the corrective treatment for bunion. Results have potential to improve surgical treatment outcomes and, improve upon the current methods of fluoroscopic motion analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bunion
Patients being treated for foot bunion with surgery.
No interventions assigned to this group
Controls (normal foot)
Participants in this group will not undergo surgery.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women.
* Able to comprehend the risks associated with the study.
* Able to complete the paperwork required for enrollment.
* Able to walk without assistance of another individual.
Exclusion Criteria
* History of great toe, forefoot or arch surgery, or severe traumatic injury.
* Reduced ankle or great toe motion that impairs the ability to walk.
* Observed evidence of foot deformity other than bunion.
* Insensate to skin sensation testing which could indicate neuropathy.
18 Years
80 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ward M Glasoe, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1401M47629
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.